NCT06764277Completed
Mechanisms and Phenotypes of Hypertension in Patients in Chronic Hemodialysis
Source: ClinicalTrials.gov · Last updated 3 Feb 2026
Brief summary (registry, in English)
The goal of this study is to evaluate interdialytic blood pressure changes of the patients in chronic hemodialysis. The main question to be answered is: What is the relative importance of weight gain, the renin angiotensin system, the sympathetic nervous system and inflammatory immune reactivity in the interdialytic hypertension of patients in chronic hemodialysis, The participants will have hemodynamic evaluation (cardiac output and peripheral vascular resistance) at the end of dialysis, ambulatory monitoring of blood pressure in the interdialytic period. Serum samples will be collected at the end of dialysis and before the start of the next dialysis, 2-3 days later.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 32 (actual)
- First submitted
- 19 Dec 2024
- Start date
- 14 Aug 2023
- Primary completion date
- 20 Dec 2024
- Lead sponsor
- Bernardo Rodríguez Iturbe
- Diseases
- High blood pressure
- NCT number
- NCT06764277
What you commit to
- Study type: Observational
- Participants enrolled: 32
- From 14 Aug 2023 to the primary completion date, 20 Dec 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Prior nephrectomy
Other illness
- Patients with active infection
Other
- Patients unable to give informed consent or withdrawal of informed consent to the study
- Patients with prosthesis or pacemakers
- Patients with immunosuppressive treatment of more than 10mg Prednisone daily
- incomplete collection of data specified in the study protocol
Who the study is looking for
- Patients with more than 3 months in the chronic hemodialysis program in the INCMNSZ and assumed to remained in the program for longer than 3 months
- Stable patients with no change in medication 1 month prior to the study
- Unchanged drug therapy and dialysis prescription for \>1 month prior to the studies
- Informed consent to participate in the study
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán Coordinator of this site? Confirm its status | Mexico City | Mexico | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.